Taiwan FDA registration 5e73800d4fab0641cc2d21d4f796067c

Formosa One Sure MDMA rapid test kit

TW: 台塑生醫迅知3,4-亞甲基雙氧甲基安非他命(搖頭丸)快速檢驗試劑
Taiwan flagTaiwan·Risk Class 2·MD·Formosa Biomedical Technology Co., Ltd. Yilan Factory·Registered May 22, 2019 – May 22, 2024Expired
Registration details
Analysis ID
5e73800d4fab0641cc2d21d4f796067c
License Form
Ministry of Health Medical Device Manufacturing No. 006297
Company information
Manufacturer Country
Taiwan, Province of China
Product details
Intended Use
This product uses competitive immunochromatography to qualitatively detect 3,4-methylenedioxymethamphetamine (ecstasy) in human urine, and the test results can only be used for preliminary screening. The threshold standard for ecstasy is 500 ng/mL. This product can be used by both individuals and professionals.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A3610 Methamphetamine Test System
Import Information
Produced in Taiwan, China
Dates and status
Registration Date
May 22, 2019
Expiry Date
May 22, 2024
About this record

Access comprehensive regulatory information for Formosa One Sure MDMA rapid test kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5e73800d4fab0641cc2d21d4f796067c and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory. The authorized representative in Taiwan is FORMOSA BIOMEDICAL TECHNOLOGY CORPORATION.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices